Thus, regarding its role in CRC, it has been shown that aberrant methylation of DIRAS1 is related to the poor prognosis of CRC patients, and it acts as an inhibitor of cell proliferation, migration, and invasion in CRC. The gene discussed is DIRAS1; the disease is colorectal carcinoma.